PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)
CUSIP: 74587V107
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,633,071
- Total 13F shares
- 36,681,359
- Share change
- +1,182,755
- Total reported value
- $4,391,736,256
- Put/Call ratio
- 84%
- Price per share
- $119.75
- Number of holders
- 170
- Value change
- +$169,794,588
- Number of buys
- 102
- Number of sells
- 71
Quarterly Holders Quick Answers
What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74587V107:
Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.9%
|
3,433,672
|
$300,103,000 | — | 30 Jun 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6.7%
|
3,350,000
|
$292,790,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
5.1%
|
2,520,048
|
$220,252,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
2,474,644
|
$216,284,000 | — | 30 Jun 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4.9%
|
2,425,735
|
$212,009,000 | — | 30 Jun 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.7%
|
1,857,631
|
$162,302,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
1,830,342
|
$159,973,000 | — | 30 Jun 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.4%
|
1,707,163
|
$149,207,000 | — | 30 Jun 2017 | |
| PFM Health Sciences, LP |
13F
|
Company |
3.4%
|
1,682,158
|
$147,021,000 | — | 30 Jun 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.9%
|
1,455,361
|
$127,199,000 | — | 30 Jun 2017 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
1,215,354
|
$106,225,000 | — | 30 Jun 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.9%
|
937,797
|
$81,963,000 | — | 30 Jun 2017 | |
| Redmile Group, LLC |
13F
|
Company |
1.7%
|
860,456
|
$75,204,000 | — | 30 Jun 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
733,320
|
$64,092,000 | — | 30 Jun 2017 | |
| PointState Capital LP |
13F
|
Company |
1.2%
|
605,360
|
$52,908,000 | — | 30 Jun 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
573,619
|
$50,134,000 | — | 30 Jun 2017 | |
| NORGES BANK |
13F
|
Company |
1%
|
501,322
|
$43,815,000 | — | 30 Jun 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.96%
|
474,717
|
$41,491,000 | — | 30 Jun 2017 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.77%
|
379,734
|
$32,942,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
347,665
|
$30,386,000 | — | 30 Jun 2017 | |
| Bain Capital Public Equity Management, LLC |
13F
|
Company |
0.68%
|
338,994
|
$29,628,000 | — | 30 Jun 2017 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.64%
|
317,680
|
$27,765,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.52%
|
258,540
|
$22,596,000 | — | 30 Jun 2017 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.5%
|
248,038
|
$21,679,000 | — | 30 Jun 2017 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.43%
|
213,000
|
$18,616,000 | — | 30 Jun 2017 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
207,884
|
$18,169,000 | — | 30 Jun 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.41%
|
202,537
|
$17,702,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.4%
|
200,354
|
$17,509,000 | — | 30 Jun 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.4%
|
200,168
|
$17,495,000 | — | 30 Jun 2017 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.37%
|
186,000
|
$16,256,000 | — | 30 Jun 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
164,104
|
$14,339,000 | — | 30 Jun 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.31%
|
152,898
|
$13,363,000 | — | 30 Jun 2017 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.3%
|
150,000
|
$13,110,000 | — | 30 Jun 2017 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.3%
|
150,000
|
$13,110,000 | — | 30 Jun 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
148,568
|
$12,985,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
136,297
|
$11,912,000 | — | 30 Jun 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.27%
|
131,900
|
$11,528,000 | — | 30 Jun 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.25%
|
123,380
|
$10,784,000 | — | 30 Jun 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.25%
|
123,114
|
$10,760,000 | — | 30 Jun 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.22%
|
107,200
|
$9,369,000 | — | 30 Jun 2017 | |
| Boxer Capital, LLC |
13F
|
Company |
0.2%
|
100,000
|
$8,740,000 | — | 30 Jun 2017 | |
| Tourbillon Capital Partners, L.P. |
13F
|
Company |
0.2%
|
100,000
|
$8,740,000 | — | 30 Jun 2017 | |
| HBK INVESTMENTS L P |
13F
|
Company |
0.19%
|
93,993
|
$8,215,000 | — | 30 Jun 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
84,062
|
$7,347,000 | — | 30 Jun 2017 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
80,498
|
$7,036,000 | — | 30 Jun 2017 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.16%
|
80,021
|
$6,994,000 | — | 30 Jun 2017 | |
| Quantitative Investment Management, LLC |
13F
|
Company |
0.16%
|
79,400
|
$6,939,000 | — | 30 Jun 2017 | |
| Laurion Capital Management LP |
13F
|
Company |
0.13%
|
66,846
|
$5,842,000 | — | 30 Jun 2017 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
65,762
|
$5,747,000 | — | 30 Jun 2017 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
60,126
|
$5,255,000 | — | 30 Jun 2017 |
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q3 2017
As of 30 Sep 2017,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,681,359 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, FMR LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., Partner Fund Management, L.P., STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
170
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
152
Q3 2017 holders
170
Holder diff
18
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.